The aryl hydrocarbon receptor (AHR) and the ␣-class hypoxia inducible factors (HIF1␣, HIF2␣, and HIF3␣) are basic helix-loop-helix PAS (bHLH-PAS) proteins that heterodimerize with ARNT. In response to 2,3,7,8-tetrachlorodibenzo-p-dioxin, the AHR⅐ARNT complex binds to "dioxin responsive enhancers" (DREs) and activates genes involved in the metabolism of xenobiotics, e.g. cytochrome P4501A1 (Cyp1a1). The HIF1␣⅐ARNT complex binds to "hypoxia responsive enhancers" and activates the transcription of genes that regulate adaptation to low oxygen, e.g. erythropoietin (Epo). We postulated that activation of one pathway would inhibit the other due to competition for ARNT or other limiting cellular factors. Using pathway specific reporters in transient transfection assays, we observed that DRE driven transcription was markedly inhibited by hypoxia and that hypoxia responsive enhancer driven transcription was inhibited by AHR agonists. When we attempted to support this cross-talk model using endogenous loci, we observed that activation of the hypoxia pathway inhibited Cyp1a1 up-regulation, but that activation of the AHR actually enhanced the induction of Epo by hypoxia. To explain this unexpected additivity, we examined the Epo gene and found that its promoter harbors DREs immediately upstream of its transcriptional start site. These experiments outline conditions where inhibitory and additive cross-talk occur between the hypoxia and dioxin signal transduction pathways and identify Epo as an AHR-regulated gene.
The AHR1 regulates a variety of biological responses to environmentally ubiquitous polycyclic aromatic hydrocarbons and dioxins (1,2). In what can be defined as an adaptive pathway, the AHR up-regulates a battery of XMEs that often metabolize many of these agonists to more soluble and excretable products. A classic example of this pathway is observed upon exposure to benzo [a]pyrene. This chemical binds to the AHR leading to the up-regulation of a battery of genes including Cyp1a1, Cyp1a2, and Cyp1b1 (3). The enzymes encoded by these loci have metabolic activity toward benzo[a]pyrene and thus play an important role in its elimination (4). At present, we understand many of the molecular events in what appears to be an adaptive response to polycyclic aromatic hydrocarbon exposure. In brief, the up-regulation of genes like Cyp1a1 are regulated by an agonist-induced heterodimerization between two bHLH-PAS proteins, the AHR and ARNT (5, 6). This heterodimeric pair interacts with DREs upstream of the regulated promoters leading to an increase in their transcription rate and a resultant increase in XME activity (7).Although we have developed models to describe how the AHR regulates the expression of XMEs, we still have very little knowledge about how this protein mediates the toxicity of potent agonists like dioxin. The molecular mechanisms of dioxin-induced effects like lymphoid involution, epithelial hyperplasia, tumor promotion, teratogenesis, or even death remain unclear. Moreover, although genetic studies indicate the ...